Fuyuan Pharmaceutical (601089.SH): Rotigotine Patch Obtained Drug Registration Certificate

Zhitong Finance APP News, Fuyuan Pharmaceutical (601089.SH) announced that recently, the company received the Rotigotine Transdermal Patch (specification: 2mg/24 hours, 4.5mg/patch) "Drug Registration Certificate" (Certificate No.: 2026S03864) issued by the National Medical Products Administration, approving the production of this drug.